Aveanna Healthcare Holdings Inc. (AVAH) surged 5.03% intraday as multiple analysts raised their price targets for the stock, signaling improved market sentiment.

UBS increased its price target to $10 from $9.50 while maintaining a Neutral rating, while RBC Capital raised its target to $11 from $10 and kept a Sector Perform rating. These adjustments reflect growing optimism about the company's prospects among Wall Street analysts.